Opus Genetics, Inc. (IRD) Profit Margins
Over the twelve months to 2026-06-30, Opus Genetics, Inc. (IRD) had operating margin -513.5%, net margin -1091.8%, free cash flow margin -357.7%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IRDOpus Genetics, Inc.Follow IRD — free
—
Price chart with a free account
- Market cap
- 288.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2019 Dec 19 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | 64.0% | 7.3% | — | — | — | |
| Operating margin | -139.8% | -3854.8% | 45.7% | -55.5% | -564.7% | -271.9% | -513.5% | |
| Net margin | -205.6% | -9625.3% | 44.9% | -52.4% | -523.4% | -349.3% | -1091.8% | |
| FCF margin | -120.4% | — | — | — | -232.7% | -248.3% | -357.7% |
USD millions · SEC XBRL
Opus Genetics, Inc. — questions
- What is Opus Genetics, Inc.'s operating margin?
- -513.5% over the twelve months to 2026-06-30.
- What is Opus Genetics, Inc.'s net profit margin?
- -1091.8% over the twelve months to 2026-06-30.
Every figure on this page comes from Opus Genetics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.